FDA Revolutionizes Drug Research! AI Calculations and Human-Based Models are to Eliminate Animal Testing!
Reading Time: 4 minutes
According to a press release from the U.S. Food and Drug Administration on Thursday, April 10, 2025, the FDA intends to phase out the requirement for animal testing for monoclonal antibody therapies and other drugs, replacing it with more ethical and modern methods such as AI computations and human-based models. Contract research organizations like Charles River Laboratories (CRL) and Inotiv (NOTV), which conduct preclinical animal-based research, saw significant declines in regular trading following this announcement, dropping by over double digits....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
